Browsing Tag
whole genome sequencing
2 posts
Caris Life Sciences (NASDAQ: CAI) says final Achieve 1 data strengthens the case for Caris Detect, but can MCED execution close the gap?
Caris Life Sciences says final Achieve 1 data strengthens Caris Detect. Read why the MCED opportunity looks bigger, and why execution risk still matters.
SOPHiA GENETICS teams up with Microsoft and NVIDIA to advance genomic research
SOPHiA GENETICS (Nasdaq: SOPH), renowned for its prowess in cloud-native healthcare technology, announced a significant expansion in its…